Empowered Patient Podcast

Dr. Oleg Bess is the Founder and CEO of 4medica and a practicing OB/GYN, and a strong believer in allowing patients to have easy access to their health data in order to equalize healthcare across all categories of patients.

Oleg says, "4medica's mission is really to formulate a one patient, one record paradigm, where we are able to access a number of data sources for a patient. We have the engine that is able to, on-the-fly, real-time actually, add these records into the correct chart. Even in this country where there's no unique identifier for patients, we're able to look at all kinds of demographics data for the patient and on-the-fly place that record into the correct chart."

@4medica #DataQuality #DataAccess #Healthcare #HealthIT #SDOH #Outcomes #DigitalHealth

4medica.com

Listen to the podcast here

Dr. Oleg Bess is the Founder and CEO of 4medica and a practicing OB/GYN, and a strong believer in allowing patients to have easy access to their health data in order to equalize healthcare across all categories of patients.

Oleg says, "4medica's mission is really to formulate a one patient, one record paradigm, where we are able to access a number of data sources for a patient. We have the engine that is able to, on-the-fly, real-time actually, add these records into the correct chart. Even in this country where there's no unique identifier for patients, we're able to look at all kinds of demographics data for the patient and on-the-fly place that record into the correct chart."

@4medica #DataQuality #DataAccess #Healthcare #HealthIT #SDOH #Outcomes #DigitalHealth

4medica.com

Download the transcript here

Dr. Steve Worland is President and CEO of eFFECTOR Therapeutics a pioneer in the Genomics 3.0 category putting to work the research on selective translation regulator inhibitors (STRIs) and the key ways that cancer cells change their behavior and also change the immune system.

Steve says, "There are two revolutions in cancer in the last 10 to 15 years-- targeted therapies and immunotherapies. And we think STRIs is a third way to compliment one or both of those. And really with the idea here is that you could control a cancer for a long period of time. It's very hard to completely eradicate every tumor and every cancer cell in your body.

"But if you can restore control, your immune system can control the cancer. Hopefully, patients can live for years knowing they have the disease but not having it debilitate their daily life."

#eFFECTORTherapeutics #NSCLC #STRIs #cancer #SPAC

eFFECTOR.com

Listen to the podcast here

Dr. Steve Worland is President and CEO of eFFECTOR Therapeutics a pioneer in the Genomics 3.0 category putting to work the research on selective translation regulator inhibitors (STRIs) and the key ways that cancer cells change their behavior and also change the immune system.

Steve says, "There are two revolutions in cancer in the last 10 to 15 years-- targeted therapies and immunotherapies. And we think STRIs is a third way to compliment one or both of those. And really with the idea here is that you could control a cancer for a long period of time. It's very hard to completely eradicate every tumor and every cancer cell in your body.

"But if you can restore control, your immune system can control the cancer. Hopefully, patients can live for years knowing they have the disease but not having it debilitate their daily life."

#eFFECTORTherapeutics #NSCLC #STRIs #cancer #SPAC

eFFECTOR.com

Download the transcript here

Bret Larsen is the CEO and Co-Founder of eVisit, a virtual care platform that is serving the largest health systems in the country to establish remote access for a telemedicine solution that works for patients as well as hospitals, doctors, and administrators.

Bret says, "One of the things the pandemic accelerated in a big, big way was the consumerization of care. It forced us, as consumers, not patients, but consumers, to look for more options. With many physical encounters being closed or highly limited, we had to start looking for other options."

"I strongly believe that the future exam room will be your living room, or your bedroom, or somewhere where you can be diagnosed and suggested treatment, and then directed to the most appropriate point of care, whether that be an asynchronous interaction, a synchronous interaction, or the physical exam room at the hospital. So, the interoperability piece is enormous. It stands to accelerate the improvement of patient outcomes in a big, big way."

The eVisit Enterprise Virtual Care Platform was named the Solo Leader by Forrester Research in The Forrester Wave ™: Virtual Care Platforms for Digital Health, Q1 2021. Download your complimentary report here.

@BretALarsen @eVisit #Telehealth #VirtualCare #Telemedicine #DigitalHealth

eVisit.com

Listen to the podcast here

Bret Larsen is the CEO and Co-Founder of eVisit, a virtual care platform that is serving the largest health systems in the country to establish remote access for a telemedicine solution that works for patients as well as hospitals, doctors, and administrators.

Bret says, "One of the things the pandemic accelerated in a big, big way was the consumerization of care. It forced us, as consumers, not patients, but consumers, to look for more options. With many physical encounters being closed or highly limited, we had to start looking for other options."

"I strongly believe that the future exam room will be your living room, or your bedroom, or somewhere where you can be diagnosed and suggested treatment, and then directed to the most appropriate point of care, whether that be an asynchronous interaction, a synchronous interaction, or the physical exam room at the hospital. So, the interoperability piece is enormous. It stands to accelerate the improvement of patient outcomes in a big, big way."

The eVisit Enterprise Virtual Care Platform was named the Solo Leader by Forrester Research in The Forrester Wave ™: Virtual Care Platforms for Digital Health, Q1 2021. Download your complimentary report here.

@BretALarsen @eVisit #Telehealth #VirtualCare #Telemedicine #DigitalHealth

eVisit.com

Download the transcript here

John Zaleski Ph.D. NREMT, CAP, CPHIMS is the head of clinical informatics at Capsule. The topic is medical device integration to track progress and improve hospital care with continuous patient data collection and surveillance with prompts for action.

John says, "Aside from the physics of actually connecting and pulling the data, there are all sorts of IT-related issues of how to store the data, how to correctly format the data for communication. Now, there are standards that have been developed over the years that are in use today that tend to make those types of challenges less formidable. But having data access from any location in the hospital continues to be a little bit of a challenge in terms of lower acuity settings versus higher acuity settings."

"And so you have a mix of devices that do communicate, a mix of devices that communicate in a proprietary manner, and then medical devices that communicate more ubiquitously using standards like Health Level 7, various flavors of the Health Level 7 standard. It's a mishmash. But as time goes on and devices are migrated out of the environment, and newer ones are migrated in, they typically are adhering to a standard, which is a flavor of HL7."

#ActionableInsights #ConnectedCare #ClinicianBurnout #HealthIT #MedicalDeviceIntegration #PtSafety #CapsuleTech

CapsuleTech.com

Listen to the podcast here

John Zaleski Ph.D. NREMT, CAP, CPHIMS is the head of clinical informatics at Capsule. The topic is medical device integration to track progress and improve hospital care with continuous patient data collection and surveillance with prompts for action.

John says, "Aside from the physics of actually connecting and pulling the data, there are all sorts of IT-related issues of how to store the data, how to correctly format the data for communication. Now, there are standards that have been developed over the years that are in use today that tend to make those types of challenges less formidable. But having data access from any location in the hospital continues to be a little bit of a challenge in terms of lower acuity settings versus higher acuity settings."

"And so you have a mix of devices that do communicate, a mix of devices that communicate in a proprietary manner, and then medical devices that communicate more ubiquitously using standards like Health Level 7, various flavors of the Health Level 7 standard. It's a mishmash. But as time goes on and devices are migrated out of the environment, and newer ones are migrated in, they typically are adhering to a standard, which is a flavor of HL7."

#ActionableInsights #ConnectedCare #ClinicianBurnout #HealthIT #MedicalDeviceIntegration #PtSafety #CapsuleTech

CapsuleTech.com

Download the transcript here

Emily Parks is a behavioral and patient advocate and the Founder of POP! --Pissed Off Patients-- with a mission to educate healthcare professionals and patients about medical PTSD. Born with a rare intestinal illness called Myopathic intestinal pseudo-obstruction, her own medical journey has led to awareness about medical PTSD and the drive to pursue a Ph.D. in medical trauma and become a patient advocate.

Emily says, "I find as an adult, a lot of the trauma that I've received in the healthcare system and interacting with the healthcare system has impacted me in how I socialize with both providers and non-providers as much as friends."

"Socially, it's impacted my thinking style. It's impacted my ability to trust and connect with others. And so that is what POP! is about. What is Medical PTSD, and how does it manifest in you? What are some coping mechanisms?"

#MedicalPTSD #PTSD #PTSDAwareness #MedicalTrauma #PatientSafety #PatientExperience #RareDisease

POPMedicalPTSD.org

Listen to the podcast here

Emily Parks is a behavioral and patient advocate and the Founder of POP! --Pissed Off Patients-- with a mission to educate healthcare professionals and patients about medical PTSD. Born with a rare intestinal illness called Myopathic intestinal pseudo-obstruction, her own medical journey has led to awareness about medical PTSD and the drive to pursue a Ph.D. in medical trauma and become a patient advocate.

Emily says, "I find as an adult, a lot of the trauma that I've received in the healthcare system and interacting with the healthcare system has impacted me in how I socialize with both providers and non-providers as much as friends."

"Socially, it's impacted my thinking style. It's impacted my ability to trust and connect with others. And so that is what POP! is about. What is Medical PTSD, and how does it manifest in you? What are some coping mechanisms?"

#MedicalPTSD #PTSD #PTSDAwareness #MedicalTrauma #PatientSafety #PatientExperience #RareDisease

POPMedicalPTSD.org

Download the transcript here